The XXII chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the XXII chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The XXII stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View XXII Detailed Price Forecast - CNN Money||View XXII Detailed Summary - Google Finance|
|View XXII Detailed Summary - Yahoo! Finance||View XXII Stock Research & Analysis - Zacks.com|
|View XXII Trends & Analysis - Trade-Ideas||View XXII Major Holders - Barrons|
|View XXII Call Transcripts - NASDAQ||View XXII Breaking News & Analysis - Seeking Alpha|
|View XXII Annual Report - CompanySpotlight.com||View XXII OTC Short Report - OTCShortReport.com|
|View XXII Fundamentals - TradeKing||View XXII SEC Filings - Bar Chart|
|View Historical Prices for XXII - The WSJ||View Performance/Total Return for XXII - Morningstar|
|View the Analyst Estimates for XXII - MarketWatch||View the Earnings History for XXII - CNBC|
|View the XXII Earnings - StockMarketWatch||View XXII Buy or Sell Recommendations - MacroAxis|
|View the XXII Bullish Patterns - American Bulls||View XXII Short Pain Metrics - ShortPainBot.com|
|View XXII Stock Mentions - StockTwits||View XXII Stock Mentions - PennyStockTweets|
|View XXII Stock Mentions - Twitter||View XXII Investment Forum News - Investor Hub|
|View XXII Stock Mentions - Yahoo! Message Board||View XXII Stock Mentions - Seeking Alpha|
|View Insider Transactions for XXII - SECform4.com||View Insider Transactions for XXII - Insider Cow|
|View XXII Major Holdings Summary - CNBC||View Insider Disclosure for XXII - OTC Markets|
|View Insider Transactions for XXII - Yahoo! Finance||View Institutional Holdings for XXII - NASDAQ|
|View XXII Stock Insight & Charts - FinViz.com||View XXII Investment Charts - StockCharts.com|
|View XXII Stock Overview & Charts - BarChart||View XXII User Generated Charts - Trading View|
Investors Who Bought 22nd Century Group (NYSEMKT:XXII) Shares Three Years Ago Are Now Up 120%
Posted on Friday April 19, 2019
22nd Century Group, Inc. (NYSEMKT:XXII) shareholders might be concerned after seeing the share price drop 21% in the last quarter. But that doesn't undermine the rather lovely longer-term return, if you measure over the l...
Grossly Misleading “Short and Distort” Article Wrongfully Attempts to Dupe 22nd Century Group Shareholders
Posted on Thursday April 18, 2019
22nd Century Group, Inc. (NYSE American: XXII), a plant biotechnology company that is a world leader in tobacco harm reduction, Very Low Nicotine Content tobacco, and hemp/cannabis research, today commented on a grossly misleading article published yesterday by an anonymous self-professed short seller of the Company’s stock. Publishing under the pen name “Fuzzy Panda,” the author – who will not even identify who he is – continued his baseless smear campaign against the Company in an effort to depress the share price of 22nd Century stock and to make a personal profit by duping shareholders into selling their shares. Although 22nd Century does not normally respond to “short and distort” articles or to “hit pieces,” the Company believes the grossly misleading mischaracterizations and wrongful innuendo contained in the subject article warranted a Company response.
22nd Century Group Hires Former Imperial Brands Head of Regulatory Science
Posted on Wednesday April 17, 2019
22nd Century Group, Inc. (NYSE American:XXII), a plant biotechnology company that is a leader in tobacco harm reduction, Very Low Nicotine Content tobacco, and hemp/cannabis research, announced today the hiring of John D. Pritchard as Vice President of Regulatory Science. Mr. Pritchard was formerly the Head of Regulatory Science for Imperial Brands, U.K. (LSE:IMB).
Cannabis Stocks to Watch
Posted on Thursday April 11, 2019
HENDERSON NV / ACCESSWIRE / April 11, 2019 / With the market off to its best first quarter over the past 2 decades and the cannabis industry being one of the hottest in the market, now is an ideal time ...